MedChemExpress LLC (MCE)

MedChemExpressModel BMS-963272 - 1441057-15-3

SHARE
BMS-963272 is an orally active and selective MGAT2 inhibitor (IC50 = 7.1 nM), used for the study of metabolic disorders and inflammatory diseases[1][2].
Most popular related searches

MCE products for research use only. We do not sell to patients.

BMS-963272

MCE China:BMS-963272

Brand:MedChemExpress (MCE)

Cat. No.HY-132924

CAS:1441057-15-3

Purity:99.92%

Storage:Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month

Shipping:Room temperature in continental US; may vary elsewhere.

Description:BMS-963272 is an orally active and selective MGAT2 inhibitor (IC50 = 7.1 nM), used for the study of metabolic disorders and inflammatory diseases.

In Vitro:BMS-963272 (10 min) has good metabolic properties, with 100% metabolic stability in both human and mouse liver microsomes[1].

In Vivo:BMS-963272 (30 mg/kg, p.o., twice daily, for 24 days) reduced body weight gain and significantly decreased food intake in the diet-induced obese mouse model[1]. BMS-963272 (0.3 and 3.0 mg/kg, p.o., once daily, for 8 weeks) exhibited potent antifibrotic and anti-inflammatory effects in the choline-deficient, amino acid-defined high-fat diet (CDAHFD)-induced non-alcoholic steatohepatitis (NASH) mouse model by reducing liver fibrosis and lowering the expression of inflammatory markers such as tumor necrosis factor-alpha (TNFa), further improving liver function as evidenced by decreased alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels[2].

Hot selling product:Nobiletin  | Favipiravir  | DSPE-PEG2000-Maleimide  | Ivosidenib  | C16-Ceramide  | Siltuximab  | 9-cis-Retinoic acid  | VER-155008  | D18  | GYY4137

Trending products:Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Fluorescent Dye  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides

References:

[1]. Turdi H, et al. Screening Hit to Clinical Candidate: Discovery of BMS-963272, a Potent, Selective MGAT2 Inhibitor for the Treatment of Metabolic Disorders. J Med Chem. 2021 Oct 14;64(19):14773-14792.  [Content Brief]

[2]. Cheng D, et al. MGAT2 inhibitor decreases liver fibrosis and inflammation in murine NASH models and reduces body weight in human adults with obesity. Cell Metab. 2022 Nov 1;34(11):1732-1748.e5.  [Content Brief]

Brand introduction:
•   MCE (MedChemExpress) has a global exclusive compound library of more than 200 kinds, and we are committed to providing the most comprehensive range of high-quality small molecule active compounds for scientific research customers around the world;
•   More than 50,000 highly selective inhibitors and agonists are involved in various popular signaling pathways and disease areas;
•   The products cover a variety of recombinant proteins, peptides, commonly used kits, more PROTAC, ADC and other characteristic products, widely used in new drug research and development, life science and other scientific research projects;
•   Provide virtual screening, ion channel screening, metabolomics analysis detection analysis, drug screening and other professional technical services;
•   It has a professional experimental center and strict quality control and verification system;
•   Provide LC/MS, NMR, HPLC, chiral analysis, elemental analysis and other quality inspection reports to ensure the high purity and high quality of products;
•   The biological activity of the products has been verified by the experiments of customers in various countries;
•   A variety of top journals such as Nature, Cell, Science and pharmaceutical patents have included the scientific research results of MCE customers;
•   Our professional team tracks the latest pharmaceutical and life science research and provides you with the latest active compounds in the world;
•   It has established long-term cooperation with the world's major pharmaceutical companies and well-known scientific research institutions。